ArticleNutrients2025
Eating Disorders and Autistic Traits Camouflaging: Insights from the EAT Study.
Article in Nutrients, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFeeding and eating disorders (FEDs) often present in comorbidity with other psychiatric conditions, with a growing body of evidence underscoring their association with autism spectrum disorder (ASD). Individuals with ASD or significant autistic traits (ATs), especially females, often engage in camouflaging strategies to mask their symptoms. However, empirical research on the role of camouflaging within this association is still emerging. This study aimed to assess the prevalence of ATs in individuals with FEDs and to examine their connection with psychological well-being, along with the role of camouflaging as a potential mediator in this association.
methodsA total of 131 individuals with FEDs were assessed through a medical record review, a socio-demographic form, and self-administered questionnaires evaluating FEDs symptoms (EDI-3) and ASD-related features (RAADS-R, AQ, EQ, CAT-Q).
resultsIn total, 16% of patients scored above the possible high ATs in clinical settings (whereas 53% exceeded the original cut-off) and 25% showed significant camouflaging, without differences between FED diagnoses. ATs were associated with both FED symptom severity and general maladjustment. Importantly, the latter was not directly explained by ATs themselves, but was mediated separately by camouflaging and FED symptomatology. After statistical adjustments, the parallel mediating pathways contributed similarly (48% and 52%).
conclusionsA considerable subset of individuals with FEDs presents significant ATs, with camouflaging arguably linked to psychological distress through a pathway parallel to that of FED symptomatology. This overlap between FEDs and ASD may be clinically meaningful, highlighting the potential importance of assessing ATs and camouflaging to support personalized diagnostic and therapeutic interventions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.